NorthStar Medical Radioisotopes Revenue
Pharmaceutical Manufacturing • 
Beloit, Wisconsin, United States • 201-500 Employees
NorthStar Medical Radioisotopes revenue & valuation
| Annual revenue | $6,900,000 |
| Revenue per employee | $23,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $22,100,000 |
| Total funding | $37,000,000 |
Key Contacts at NorthStar Medical Radioisotopes
Bryan Mazur
Director, Business Development, Cdmo/Cmo
Gary Smith
Director, Cdmo
Chad Bidlingmaier
Director Customer Support
Andrew Maerz
Senior Director Procurement & Logistics
Alan Faust
Senior Director Ehs
Johanna Sloss
Director Of Isotope Sales
Elizabeth Vehige
Director, Human Resources
Shelley Ryan Carlson
Senior Director, Manufacturing
Jessica Sable
Director, Automation And Chemical Processing
Tyler Drum
Director, Cdmo Product Development
Company overview
| Headquarters | 1800 Gateway Boulevard, Beloit, Wisconsin 53511, US |
| Phone number | +18444386659 |
| Website | |
| NAICS | 3254 |
| SIC | 382 |
| Founded | 2006 |
| Employees | 201-500 |
| Socials |
NorthStar Medical Radioisotopes Email Formats
NorthStar Medical Radioisotopes uses 3 email formats. The most common is {first name}{last name} (e.g., johndoe@northstarnm.com), used 50.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@northstarnm.com | 50.4% |
{first initial}{last name} | jdoe@northstarnm.com | 43.3% |
{last name}{last name} | doedoe@northstarnm.com | 3.6% |
About NorthStar Medical Radioisotopes
At NorthStar Medical Radioisotopes, our mission is to provide patients global access to game-changing radiopharmaceuticals. We are a growing, commercial-stage company focused on advancing patient care by providing therapeutic radioisotopes and novel radiopharmaceuticals to detect and treat cancer, and customized radiopharmaceutical development services. Radiopharmaceutical therapy is increasingly important for cancer treatment, and NorthStar is expanding our industry-leading position in developing commercial-scale production technologies to meet this important healthcare need. We routinely produce the therapeutic radioisotope copper-67 (Cu-67) and are poised to be one of the first commercial-scale producers of non-carrier-added (n.c.a.) actinium-225 (Ac-225), using first-in-kind and environmentally preferable electron accelerator technology. NorthStar’s Radiopharmaceutical Contract Development and Manufacturing Organization (CMDO/CMO) unit provides customized service offerings and specialized radiopharmaceutical expertise to help biopharmaceutical companies rapidly advance their development and commercial programs. At NorthStar, we prioritize professional growth of our employees. Working with our cutting-edge technology offers a stimulating and rewarding environment for talented individuals who want to be part of our exciting and growing business. We are committed to providing our employees with fulfilling work experiences and valuable career development opportunities.
Employees by Management Level
Total employees: 201-500
Seniority
Employees
Employees by Department
NorthStar Medical Radioisotopes has 213 employees across 15 departments.
Departments
Number of employees
Funding Data
Explore NorthStar Medical Radioisotopes's funding history, including investment rounds, total capital raised, and key backers.
NorthStar Medical Radioisotopes Tech Stack
Discover the technologies and tools that power NorthStar Medical Radioisotopes's digital infrastructure, from frameworks to analytics platforms.
Video players
Security
Miscellaneous
JavaScript frameworks
JavaScript libraries
JavaScript libraries
Form builders
Miscellaneous
JavaScript libraries
Miscellaneous
JavaScript libraries
CDN
Italy
France
United Kingdom
South Africa
Frequently asked questions
4.8
40,000 users
